103 related articles for article (PubMed ID: 6205780)
1. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.
Allan SG; Gregor A; Cornbleet MA; Leonard RC; Smyth JF; Grant IW; Crompton GK
Cancer Chemother Pharmacol; 1984; 13(2):106-8. PubMed ID: 6205780
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
3. Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
Joss RA; Obrecht JP; Jungi WF; Alberto P; Sauter C; Cavalli F
Cancer Chemother Pharmacol; 1984; 13(2):148-9. PubMed ID: 6088102
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Niederle N; Schütte J; Schmidt CG; Seeber S
Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
[TBL] [Abstract][Full Text] [Related]
5. Vindesine and etoposide chemotherapy in the management of patients with small cell lung cancer and poor prognosis.
Iredale JP; Hooi LM; Kerr KM; Sudlow MF; Wathen CG
Respiration; 1991; 58(2):77-80. PubMed ID: 1650490
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
8. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
[TBL] [Abstract][Full Text] [Related]
9. Progress in chemotherapy of non-small cell lung cancer.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1329-33. PubMed ID: 6209142
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
[TBL] [Abstract][Full Text] [Related]
11. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
[TBL] [Abstract][Full Text] [Related]
12. [3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Liesenfeld A; Havemann K; Gropp C; Seifert W; Thomas C; Drings P; Mahnke HG; Westerhausen M; Wellens W; Konrad RM
Onkologie; 1984 Jun; 7(3):145-51. PubMed ID: 6087231
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Drings P; Manke HG
Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
[TBL] [Abstract][Full Text] [Related]
14. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of vindesine in patients with small cell lung carcinoma.
Natale RB; Gralla RJ; Wittes RE
Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
[No Abstract] [Full Text] [Related]
16. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
[TBL] [Abstract][Full Text] [Related]
17. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
König HJ; Arnold E; Walter M; Sander U
Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
Bishop JF; Raghavan D; Stuart-Harris R; Morstyn G; Aroney R; Kefford R; Yuen K; Lee J; Gianoutsos P; Olver IN
J Clin Oncol; 1987 Oct; 5(10):1574-8. PubMed ID: 2821197
[TBL] [Abstract][Full Text] [Related]
20. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
James LE; Gower NH; Rudd RM; Spiro SG; Harper PG; Trask CW; Partridge M; Ruiz de Elvira MC; Souhami RL
Br J Cancer; 1996 Jun; 73(12):1563-8. PubMed ID: 8664131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
